News

A new FTC lawsuit against Hims & Hers puts a fundamental digital-business question in the spotlight: When a health-care journey is designed for speed and convenience, are consumers still given a meaningful opportunity to understand and affirmatively accept what happens next? The case is FTC v. Hims & Hers Health, Inc., No. 3:26-cv-07871 (N.D. Cal. filed July 29, 2026). The FTC, joined by California and Utah, alleges that Hims & Hers crossed the line in its subscription, billing, cancellation, and data-sharing practices. Hims & Hers responded the same day, posting on X and issuing an investor press release that strongly disputed that account, called the claims “baseless,” and accused the FTC of disregarding evidence developed during a nearly three-year investigation.

At the center of the complaint is the company’s online intake process. Regulators allege that messaging such as “free consult,” “Due Now – $0,” and “You will only be charged if prescribed” led consumers to expect an opportunity to review and discuss a recommended treatment before committing, but that many were instead charged and enrolled in a recurring prescription plan once a provider approved treatment. Hims & Hers responds that its customers receive the information needed to make informed decisions and argues that the government’s theory ignores established telehealth laws and industry standards.

The complaint also challenges how the company handled refills and cancellations. It alleges that refill charges could be processed earlier than consumers expected and that cancellation routes were unnecessarily difficult, first requiring consumers to contact customer service and later routing them through an online flow in which the cancellation option appeared only after several less-than-obvious steps. Hims & Hers rejects the broader suggestion that its systems deprived customers of informed choice, maintaining that it has continued to strengthen its processes as the platform has grown.

The privacy allegations may carry even broader implications for digital health companies. Regulators claim that, despite advertising its services as private, secure, and discreet, Hims & Hers shared sensitive health-related information with advertising platforms, including Meta and Snap, through customer lists and tracking technologies. The company counters that its privacy policy gives customers choices about data use and that information patients share with health-care providers is used only to provide care.

Legally, the FTC asserts claims under the FTC Act and the Restore Online Shoppers’ Confidence Act. California, appearing through Los Angeles County Counsel, brings claims under its Unfair Competition Law and False Advertising Law, including alleged violations of California’s Automatic Renewal Law, and Utah’s Division of Consumer Protection sues under the Utah Consumer Sales Practices Act. Collectively, the plaintiffs seek injunctive relief, monetary remedies, restitution, and civil penalties. For now, these remain allegations: the complaint was filed in the Northern District of California on July 29, 2026, and, as of July 30, 2026, Hims & Hers has not yet filed a response in court, discovery has not commenced, and no court has determined liability. The company has indicated that it intends to defend the case vigorously.

The broader point of this case and the allegations contained therein is not limited to telehealth. Businesses built around subscriptions, personalized digital experiences, and data-driven marketing should expect increasing scrutiny of the full customer journey: not only what disclosures say, but when they appear, how prominently they are presented, and whether consent and cancellation are genuinely straightforward. This case may become an important test of how consumer-protection principles apply when health care, recurring commerce, and advertising technology converge. Where do you see the line between a frictionless checkout and a consent problem?